AK Medical Holdings Limited (HKG:1789)
Hong Kong
· Delayed Price · Currency is HKD 6.08
-0.15 (-2.41%)
Apr 3, 2025, 4:08 PM HKT
AK Medical Holdings Revenue
In the year 2024, AK Medical Holdings had annual revenue of 1.35B CNY with 23.08% growth. AK Medical Holdings had revenue of 689.28M in the half year ending December 31, 2024, with 32.34% growth.
Revenue
1.35B CNY
Revenue Growth
+23.08%
P/S Ratio
4.74
Revenue / Employee
1.41M CNY
Employees
954
Market Cap
6.83B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.35B | 252.52M | 23.08% |
| Dec 31, 2023 | 1.09B | 41.82M | 3.97% |
| Dec 31, 2022 | 1.05B | 290.61M | 38.17% |
| Dec 31, 2021 | 761.44M | -273.95M | -26.46% |
| Dec 31, 2020 | 1.04B | 108.68M | 11.73% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Alibaba Health Information Technology | 31.39B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |